PURPOSE: This retrospective case series aims to document healthcare providers' (HCP) real-world experience of using the enVista ENVY toric (ETN) intraocular lens (IOL), including satisfaction, IOL utilization patterns, and patient outcomes. This interim sub-analysis reports the patient outcomes.

METHODS: This sub-analysis of a multicenter, cross-sectional, retrospective case series includes case report forms (CRFs) from 11 HCPs from the USA (n=10) and Canada (n=1). HCPs provided ETN electronic medical record cases using a standardized CRF to document real-world clinical performance. Key outcome measures included monocular and binocular vision outcomes (uncorrected distance visual acuity [UDVA], corrected distance visual acuity [CDVA], uncorrected intermediate visual acuity [UIVA], uncorrected near visual acuity [UNVA]), mean refractive spherical equivalent (MRSE), and adverse events (AEs).

RESULTS: Preliminary analysis included 110 pts (168 eyes): 52 unilateral. Mean±SD preop delta K and spherical equivalent target were 1.05±0.53 and -0.04±0.21 (n=167). Monocular vision outcomes were: CDVA of 20/25 or better was achieved in 94% of eyes (n=124); UDVA of 20/32 or better in 83% of eyes (n=151); UIVA of 20/32 or better in 89% of eyes (n=78); UNVA of J2 or better in 66% of eyes (n=118). Mean±SD MRSE and residual cylinder were -0.15±0.42 and -0.46±0.43 (n=111), respectively. No serious adverse events reported.

CONCLUSION: In the cases provided, most patients achieved good distance, intermediate, and near vision, with no reported glistening.